Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Der nächste Perpetua? Warum NevGolds neueste Bohrergebnisse den Vergleich mit dem Milliardenwert PPTA nähren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CU16 | ISIN: SE0015346424 | Ticker-Symbol: 9R5
Stuttgart
06.06.25 | 08:09
0,000 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SPERMOSENS AB Chart 1 Jahr
5-Tage-Chart
SPERMOSENS AB 5-Tage-Chart

Aktuelle News zur SPERMOSENS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoSPERMOSENS: The capital raise and issue announced in March 2025 is approved by Inspectorate of Strategic Products1
DoLast day of trading in warrants series TO 5 in Spermosens is 12 June 20252
MoSPERMOSENS: The subscription price for warrants of series TO 5 has been determined - the exercise period begins today2
26.05.Spermosens publishes annual report for the financial year 20241
SPERMOSENS Aktie jetzt für 0€ handeln
15.05.NOTICE OF ANNUAL GENERAL MEETING 2025 IN SPERMOSENS AB (publ)1
07.05.Spermosens AB (publ)INTERIM REPORT JANUARY - MARCH 20251
30.04.Spermosens provides update on clinical progress, partner discussions and financing2
02.04.Spermosens reports positive second interim results from clinical study1
31.03.Spermosens appoints Dr. Jaime Castillo-León as chief technology officer to drive innovation and technology development1
27.03.Spermosens AB announces strategic collaboration with Scalania AG to accelerate development and market readiness1
21.03.Spermosens publishes peer-reviewed article on JUNO-Checked technology1
14.03.Spermosens presents plan to achieve positive cash flow following recent strategic investment1
05.03.Spermosens announces outcome of TO3 warrants1
04.03.Spermosens secures SEK 10.8 million strategic investment through directed issue, fulfilling capital need until cash positive1
24.02.Spermosens announces last day of trading for warrants of series TO31
24.02.Spotlight Stock Market: Market Notice 45/25- Last day of trading in Spermosens AB's (publ) subscription option SPERM TO 31
19.02.Spermosens AB announces shareholding changes following latest directed issue1
17.02.Announcement from the Extraordinary General Meeting of Spermosens AB (publ) on 17 February 20251
13.02.Spermosens AB (publ) YEAR-END REPORT JANUARY - DECEMBER 20243
13.02.Spermosens adjusts publication date for Year-end report 20245
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1